§ Library · Publication
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
Publication
2011
Phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in newly diagnosed estrogen receptor positive breast cancer patients.